• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外分泌性胰腺癌切除术的结果:来自法国外科学会的一项研究

Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery.

作者信息

Baumel H, Huguier M, Manderscheid J C, Fabre J M, Houry S, Fagot H

机构信息

Department of Digestive Surgery, Hôpital Saint Eloi, Montpellier, France.

出版信息

Br J Surg. 1994 Jan;81(1):102-7. doi: 10.1002/bjs.1800810138.

DOI:10.1002/bjs.1800810138
PMID:7906180
Abstract

A multicentre retrospective study was carried out to analyse short- and long-term results of 787 pancreatic resections performed for cancer between 1982 and 1988. The postoperative mortality rate was 10 per cent and the morbidity rate 35 per cent. Age above 70 years and systemic organ failure independently influenced operative mortality. In patients surviving more than 30 days the median survival was 12.3 months and the actuarial survival rate at 5 years 12 per cent. The 5-year survival rate was lower for patients with lymph node involvement than for those without (4 versus 20 per cent, P = 0.001). The operative mortality rate was higher after total pancreatectomy than pancreatoduodenectomy (17 versus 8 per cent, P = 0.015). The median survival time and 5-year survival rate after total pancreatectomy and pancreatoduodenectomy were 11 versus 14 months and 3 versus 15 per cent respectively. Of the clinical and pathological factors studied, location of the tumour in the left pancreas was most strongly related to survival, with no survivors at 4 years. These results suggest that resection should be avoided in patients over 70 years old with systemic organ failure. Pancreatoduodenectomy remains the best procedure for resection, total pancreatectomy being performed only in patients with multifocal carcinoma or those in whom a safe pancreatic anastomosis cannot be constructed.

摘要

开展了一项多中心回顾性研究,以分析1982年至1988年间因癌症进行的787例胰腺切除术的短期和长期结果。术后死亡率为10%,发病率为35%。70岁以上年龄和全身器官衰竭独立影响手术死亡率。存活超过30天的患者中位生存期为12.3个月,5年精算生存率为12%。有淋巴结转移的患者5年生存率低于无淋巴结转移的患者(4%对20%,P = 0.001)。全胰切除术后的手术死亡率高于胰十二指肠切除术(17%对8%,P = 0.015)。全胰切除术和胰十二指肠切除术后的中位生存时间和5年生存率分别为11个月对14个月和3%对15%。在所研究的临床和病理因素中,肿瘤位于胰腺左侧与生存最密切相关,4年时无存活者。这些结果表明,对于有全身器官衰竭的70岁以上患者应避免进行手术切除。胰十二指肠切除术仍然是最佳的切除手术,仅在多灶性癌患者或无法构建安全胰腺吻合的患者中进行全胰切除术。

相似文献

1
Results of resection for cancer of the exocrine pancreas: a study from the French Association of Surgery.外分泌性胰腺癌切除术的结果:来自法国外科学会的一项研究
Br J Surg. 1994 Jan;81(1):102-7. doi: 10.1002/bjs.1800810138.
2
Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.边缘可切除和局部进展期胰腺癌患者行扩大胰切除术的结果。
Br J Surg. 2016 Nov;103(12):1683-1694. doi: 10.1002/bjs.10221. Epub 2016 Sep 30.
3
Survival after resection for ductal adenocarcinoma of the pancreas.胰腺导管腺癌切除术后的生存率。
Br J Surg. 1996 May;83(5):625-31. doi: 10.1002/bjs.1800830512.
4
Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.胰腺导管腺癌根治性切除术后的长期生存。5年生存者的临床病理分析。
Ann Surg. 1996 Mar;223(3):273-9. doi: 10.1097/00000658-199603000-00007.
5
Surgery for left-sided pancreatic cancer.左侧胰腺癌的手术治疗。
Br J Surg. 1996 Aug;83(8):1065-70. doi: 10.1002/bjs.1800830810.
6
Surgical experience with pancreatic and periampullary cancer.胰腺和壶腹周围癌的手术经验。
Ann Surg. 1982 Mar;195(3):274-81. doi: 10.1097/00000658-198203000-00006.
7
Is pancreatectomy with arterial reconstruction a safe and useful procedure for locally advanced pancreatic cancer?胰腺切除术联合动脉重建术对于局部进展期胰腺癌是一种安全且有效的手术吗?
J Hepatobiliary Pancreat Surg. 2009;16(6):850-7. doi: 10.1007/s00534-009-0190-7.
8
Pancreatic carcinoma: reappraisal of surgical experiences in one Japanese university hospital.胰腺癌:日本某大学医院手术经验的重新评估
Hepatogastroenterology. 1999 Nov-Dec;46(30):3257-62.
9
[Multivisceral and extended resection in pancreatic cancer].[胰腺癌的多脏器及扩大切除术]
Langenbecks Arch Chir Suppl Kongressbd. 1992:61-5.
10
[Radical resection in patients with pancreatic head carcinomas. A retrospective survival analysis in a group of 307 subjects].[胰头癌患者的根治性切除术。对307例患者的回顾性生存分析]
Rozhl Chir. 2007 Aug;86(8):432-9.

引用本文的文献

1
Effects of Total Pancreatectomy on Survival of Patients With Pancreatic Ductal Adenocarcinoma: A Population-Based Study.全胰切除术对胰腺导管腺癌患者生存的影响:一项基于人群的研究
Front Surg. 2021 Dec 9;8:804785. doi: 10.3389/fsurg.2021.804785. eCollection 2021.
2
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision-making programme using decision tables.预防性全胰切除术在高危人群中的应用(PROPAN):使用决策表的系统评价和共享决策计划。
United European Gastroenterol J. 2020 Oct;8(8):865-877. doi: 10.1177/2050640620945534. Epub 2020 Jul 23.
3
A CARE-compliant case report: total pancreatectomy and total gastrectomy to treat pancreatic ductal adenocarcinoma.
一份符合CARE标准的病例报告:全胰切除术和全胃切除术治疗胰腺导管腺癌。
Medicine (Baltimore). 2019 Nov;98(47):e18151. doi: 10.1097/MD.0000000000018151.
4
Total pancreatectomy compared with pancreaticoduodenectomy: a systematic review and meta-analysis.全胰切除术与胰十二指肠切除术的比较:一项系统评价和荟萃分析。
Cancer Manag Res. 2019 May 7;11:3899-3908. doi: 10.2147/CMAR.S195726. eCollection 2019.
5
Advantages and Disadvantages of Prophylactic Abdominal Drainage in Distal Pancreatectomy.胰体尾切除术预防性腹腔引流的利弊
World J Surg. 2016 May;40(5):1226-35. doi: 10.1007/s00268-015-3399-4.
6
Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma.胰腺腺癌手术切除后早期死亡的相关预后因素。
Korean J Hepatobiliary Pancreat Surg. 2014 Nov;18(4):138-46. doi: 10.14701/kjhbps.2014.18.4.138. Epub 2014 Nov 30.
7
Quantifying the burden of complications following total pancreatectomy using the postoperative morbidity index: a multi-institutional perspective.使用术后发病率指数量化全胰切除术后并发症的负担:多机构视角
J Gastrointest Surg. 2015 Mar;19(3):506-15. doi: 10.1007/s11605-014-2706-y. Epub 2014 Dec 2.
8
An evaluation of neoadjuvant chemoradiotherapy for patients with resectable pancreatic ductal adenocarcinoma.可切除性胰腺导管腺癌患者新辅助放化疗的评估
HPB Surg. 2013;2013:298726. doi: 10.1155/2013/298726. Epub 2013 Jun 20.
9
Impact of total pancreatectomy: short- and long-term assessment.全胰切除术的影响:短期和长期评估
HPB (Oxford). 2013 Nov;15(11):882-92. doi: 10.1111/hpb.12054. Epub 2013 Jan 29.
10
Ductal adenocarcinoma of the pancreatic head: a focus on current diagnostic and surgical concepts.胰头导管腺癌:聚焦当前的诊断和手术概念。
World J Gastroenterol. 2012 Jun 28;18(24):3058-69. doi: 10.3748/wjg.v18.i24.3058.